Xijian Zhou

发表

The Clinical Investigation of Pemetrexed Plus Carboplatin as an Active and Tolerable Treatment Plan in Chinese Elderly Patients with Advanced Lung Adenocarcinoma

P. Li, Yan-Juan Pan, Yu-quan Wu, 2011 .

Gefitinib combined with γ-ray stereotactic body radiation therapy has better efficacy than gefitinib alone for senile lung adenocarcinoma patients with EGFR mutations as first-line regimen

Donglin Wang, Xijian Zhou, Dejian Pan, 2014 .

Clinical Analysis of Bevacizumab Plus FOLFIRI Regimen as Front-Line Therapy for Chinese Patients with Advanced Colorectal Cancer

P. Li, Jin-Ying Liang, Yu-quan Wu, 2011 .

Clinical study on gefitinib combined with γ-ray stereotactic body radiation therapy as the first-line treatment regimen for senile patients with adenocarcinoma of the lung (final results of JLY20080085)

Donglin Wang, Xijian Zhou, Dejian Pan, 2013, Molecular and clinical oncology.

Clinical study on gefitinib combined with γ-ray stereotactic radiotherapy for senile patients with adenocarcinoma of lung as the first-line regimen

Donglin Wang, Xijian Zhou, Dejian Pan, 2011 .

Up-Regulation of the Gap Junction Intercellular Communication by Tea Polyphenol in the Human Metastatie Lung Carcinoma Cell Line

Qingyong Chen, Yan-Juan Pan, Daxin Wang, 2012 .

Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil.

Xijian Zhou, Xiangyong Li, Xiangyong Li, 2015, Molecular medicine reports.

Norepinephrine Plays an Important Role in Antinociceptive Modulation of Hypothalamic Paraventricular Nucleus in the Rat

Jun Yang, Fang Hao, Daxin Wang, 2010, The International journal of neuroscience.

Phase II trial of granulocyte-macrophage colony-stimulating factor plus thalidomide in older patients with castration-resistant prostate cancer.

Xijian Zhou, Xiangyong Li, Lei Song, 2015, Molecular and clinical oncology.

The antinociceptive role of central arginine vasopressin is involved in the endogenous opiate peptide, serotonin and acetylcholine systems

Jun Yang, Yan-Juan Pan, Pei-Yong Qiu, 2011 .

A case of one lung adenocarcinoma patient harboring a novel FAM179A-ALK (F1, A19) rearrangement responding to lorlatinib treatment.

Xijian Zhou, Dejian Pan, Jing Yan, 2020, Lung cancer.